Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.
Int J Clin Oncol
; 25(3): 486-494, 2020 Mar.
Article
in En
| MEDLINE
| ID: mdl-31564004
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Prostatic Neoplasms, Castration-Resistant
/
Androgen Antagonists
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: